Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
Written by experts in the field, Biomarkers in Breast Cancer presents an updated view on the prognostic and predictive biomarkers in breast cancer covering the major advancements in the application of the novel sophisticated molecular methods as well as the conventional state-of-the art prognostic and predictive indicators. This text offers a critical view on the modern approach to the development of surrogate biomarkers of prognosis and responsiveness to selective treatments in breast cancer.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
Written by experts in the field, Biomarkers in Breast Cancer presents an updated view on the prognostic and predictive biomarkers in breast cancer covering the major advancements in the application of the novel sophisticated molecular methods as well as the conventional state-of-the art prognostic and predictive indicators. This text offers a critical view on the modern approach to the development of surrogate biomarkers of prognosis and responsiveness to selective treatments in breast cancer.